SARS-CoV-2

Melanie M Schmitt1, Annika Rössler2, Antonia Netzl3

  • 1Institute of Virology, Department of Hygiene, Microbiology and Virology, Medical University of Innsbruck, Peter-Mayr-Str. 4b, 6020 Innsbruck, Austria.

Vaccine
|July 5, 2025
PubMed
概括

连续严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 暴露会增强现有的免疫力并扩大抗体反应. 然而,随后的变种暴露主要增强交叉反应性,而不是诱导新的变种特异性抗体.